Alembic's Q2 FY 2025-26 Quarterly Results

Result Summary

• Alembic Ltd reported a 126.4% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 1.9%.
• Its expenses for the quarter were up by 7.3% QoQ and down 1.9% YoY.
• The net profit increased 108.4% QoQ and increased 6.2% YoY.
• The earnings per share (EPS) of Alembic Ltd stood at 5 during Q2 FY 2025-26.

Financial Statments for Q2 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Alembic Ltd is a well-established company operating primarily in the pharmaceutical industry. Its main products include generic pharmaceuticals, active pharmaceutical ingredients (APIs), and specialty chemicals. The company has a strong presence in both domestic and international markets. Alembic has been known for its focus on research and development, continually enhancing its product offerings. However, there are no specific recent developments or news available regarding Alembic Ltd for this quarter.

Revenue

Alembic Ltd reported a total income of ₹120.78 crores in Q2FY26, reflecting a significant quarter-over-quarter (QoQ) increase of 126.4% compared to ₹53.34 crores in Q1FY26. On a year-over-year (YoY) basis, the total income increased by 1.9% from ₹118.52 crores in Q2FY25. This indicates a strong revenue performance for the quarter, driven by an increase in sales or possibly the introduction of new products. The data does not provide a breakdown of revenue streams, but the overall growth is noteworthy.

Profitability

In Q2FY26, Alembic Ltd achieved a profit before tax of ₹84.78 crores. This represents a substantial QoQ growth of 328.2% from ₹19.80 crores in Q1FY26, and a YoY increase of 3.6% from ₹81.83 crores in Q2FY25. The tax expense for Q2FY26 was ₹8.72 crores, marking a significant increase of 338.2% from Q1FY26's ₹1.99 crores and a YoY increase of 93.3% from ₹4.51 crores in Q2FY25. The profit after tax for the quarter stood at ₹128.49 crores, which is 108.4% higher QoQ from ₹61.65 crores in Q1FY26 and 6.2% higher YoY from ₹121.02 crores in Q2FY25. Earnings per share (EPS) also grew, reaching ₹5.00 in Q2FY26, up from ₹2.40 in Q1FY26 and ₹4.71 in Q2FY25.

Operating Metrics

Total expenses for Alembic Ltd in Q2FY26 were ₹36.00 crores, showing a moderate increase of 7.3% QoQ from ₹33.54 crores in Q1FY26, while there was a slight decrease of 1.9% YoY from ₹36.68 crores in Q2FY25. The company's expense management appears steady, with expenses not significantly impacting the overall profitability. The data does not include specific metrics such as the debt-to-equity ratio, current ratio, or P/E ratio, which are often used to assess financial health and operational efficiency. However, the consistent control over expenses relative to income growth is evident.